NEI Research News

Researchers say findings reveal potential glaucoma drugs targets.

Rogue clinics offer stem cell-based therapies that haven’t been tested for safety and efficacy. When communicating to the public about stem cell-based therapies, it is important to put any treatment claims in context.

A UCLA-led group found that the eye drug verteporfin stops replication of SARS-CoV-2, the virus that causes COVID-19.

Columbia University researchers examined what goes wrong in the eyes of mice with albinism.

NEI grant will support examining impact of pain and inflammation on eye’s surface and possible link to diseases.

An unprecedented study of brain plasticity and visual perception found that people who, as children, had undergone surgery removing half of their brain correctly recognized differences between pairs of words or faces more than 80% of the time.

The brain works in fundamentally different ways when remembering what we have seen compared to seeing something for the first time, a team of scientists has found.

An enzyme under study to treat certain cancers is also showing promise in reducing the significant vision damage that can result from diabetes and premature birth, scientists report.

University of California, Irvine team demonstrates the adult brain has the potential to partially recover from inherited blindness.

Study from UT Southwestern Medical Center could lead to new treatments for deadly childhood eye cancer.